Sign in to continue:

Sunday, April 12th, 2026

Author: Minichart

Quince Therapeutics Settles $16.4 Million Debt for $5.5 Million, Advances Strategic Restructuring

Quince Therapeutics Settles \$16.4 Million Debt with EIB for...

Ultragenyx Announces FDA Clearance of IND for UX016 to Treat GNE Myopathy

Ultragenyx Pharmaceutical Inc. Files Form 8-K: Key Developme...

Realty Income Corporation Files Form 8-K With Capital and Financing Updates – March 30, 2026

Realty Income Corporation Issues Key Updates on Capital Rais...

The Manitowoc Company, Inc. Files Form 8-K Announcing Director and Officer Changes – March 2026

Manitowoc Company, Inc. — Key Corporate Developments Reporte...